Trial · NCT05141071
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Microvascular flow index | 6 hours after administration of Ivabradine or Placebo. | absent (0), intermittent (1), sluggish (2), or normal (3) |
| Secondary | Microvascular flow index | Before drug administration and at 1, 12, and 24 hours thereafter. | absent (0), intermittent (1), sluggish (2), or normal (3) |
| Secondary | Total vessel density | Before drug administration and at 1, 6,12, and 24 hours thereafter. | mm/mm2 |
| Secondary | Percentage of perfused vessels | Before drug administration and at 1, 6,12, and 24 hours thereafter. | Percentage |
| Secondary | Cardiac output | Before drug administration and at 1, 6,12, and 24 hours thereafter. | litres per minute |
| Secondary | Heart rate | Before drug administration and at 1, 6,12, and 24 hours thereafter. | beats per minute |
| Secondary | Central venous saturation | Before drug administration and at 1, 6,12, and 24 hours thereafter. | Percentage |
| Secondary | Central venous-arterial blood carbon dioxide partial pressure difference | Before drug administration and at 1, 6,12, and 24 hours thereafter. | mmHg |
| Secondary | Mean arterial blood pressure | Before drug administration and at 1, 6,12, and 24 hours thereafter. | mmHg |
| Secondary | ICU length of stay | from the date of patient recruitment till the date of discharge from the ICU or the date of death, assessed up to 28 days | Days |
| Secondary | 28 days ICU mortality | 28 days after ICU admission | Percentage |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05141071/registered